Welcome to Novo Nordisk in the United States

print email
Latest News
Feb 8, 2018

Novo Nordisk, a global healthcare company, today announced that Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated, is now available in the United States for the treatment of hemophilia B.

Feb 5, 2018

Novo Nordisk today announced the availability of two new diabetes medications, Ozempic® (semaglutide) injection 0.5 mg or 1 mg and Fiasp® (insulin aspart injection) 100 Units/mL at pharmacies across

Feb 1, 2018

Sales within diabetes care and obesity increased by 4% to USD 14.1 billion (7% in local currencies). Sales of Tresiba® increased by 81% to USD 1.1 billion (85% in local currencies). Sales of...

Jan 8, 2018

Every day, people manage a variety of serious diseases like diabetes, hemophilia, obesity or growth disorders. Some of their vital therapies are delivered by a syringe or pen injector with an...

Download Center

Visit the download center to download Novo Nordisk video and more

Stay Connected

Sign up to receive our new alerts
via e-mail